| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 11465* | 2020 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1447 | 2020 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 815 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 715 | 2021 |
| SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022 | 414 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
| Diagnosis of severe respiratory infections in immunocompromised patients E Azoulay, L Russell, A Van de Louw, V Metaxa, P Bauer, P Povoa, ... Intensive care medicine 46, 298-314, 2020 | 187 | 2020 |
| The Intensive Care Medicine research agenda on critically ill oncology and hematology patients E Azoulay, P Schellongowski, M Darmon, PR Bauer, D Benoit, P Depuydt, ... Intensive care medicine 43, 1366-1382, 2017 | 168 | 2017 |
| The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism BJ Willett, J Grove, OA MacLean, C Wilkie, N Logan, GD Lorenzo, ... MedRxiv, 2022.01. 03.21268111, 2022 | 167 | 2022 |
| Survival in solid cancer patients following intensive care unit admission K Puxty, P McLoone, T Quasim, J Kinsella, D Morrison Intensive care medicine 40, 1409-1428, 2014 | 140 | 2014 |
| Risk of critical illness among patients with solid cancers: a population-based observational study K Puxty, P McLoone, T Quasim, B Sloan, J Kinsella, DS Morrison JAMA oncology 1 (8), 1078-1085, 2015 | 123 | 2015 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
| Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: a national cohort study NI Lone, J McPeake, NI Stewart, MC Blayney, RC Seem, L Donaldson, ... The Lancet Regional Health–Europe 1, 2021 | 71 | 2021 |
| Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura E Azoulay, PR Bauer, E Mariotte, L Russell, P Knoebl, I Martin-Loeches, ... Intensive care medicine 45, 1518-1539, 2019 | 54 | 2019 |
| Long term outcomes of critically ill COVID-19 pneumonia patients: early learning C McCue, R Cowan, T Quasim, K Puxty, J McPeake Intensive care medicine 47, 240-241, 2021 | 40 | 2021 |
| A randomised, controlled, double blind, non‐inferiority trial of ultrasound‐guided fascia iliaca block vs. spinal morphine for analgesia after primary hip arthroplasty R Kearns, A Macfarlane, A Grant, K Puxty, P Harrison, M Shaw, ... Anaesthesia 71 (12), 1431-1440, 2016 | 39 | 2016 |
| COVID-19 Genomics UK (COG-UK) Consortium BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry …, 2022 | 33 | 2022 |
| Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study J McPeake, M Shaw, P MacTavish, KG Blyth, H Devine, G Fleming, ... BMJ open respiratory research 8 (1), e001080, 2021 | 30 | 2021 |
